Related Experiment Video
Updated: Aug 6, 2026

International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
Published on: March 12, 2020
The Society of Thoracic Surgeons Expert Consensus Document on Tricuspid Valve Endocarditis in People Who Inject Drugs
Joshua B Goldberg1, James Hunter Mehaffey2, Molly L Paras3
1Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York-Presbyterian Hospital, New York City, NY.
Insights
This expert consensus provides guidance for managing tricuspid valve endocarditis in people who inject drugs, addressing key clinical and surgical considerations for this challenging patient population.
Area of Science:
- Cardiovascular Surgery
- Infectious Diseases
- Public Health
Background:
- Tricuspid valve endocarditis in people who inject drugs presents unique clinical and social challenges.
- Limited research exists to guide evidence-based treatment for this specific population.
Purpose of the Study:
- To develop an expert consensus document on managing tricuspid valve endocarditis in people who inject drugs.
- To provide evidence-based recommendations for clinical practice.
Main Methods:
- A writing group was assembled by The Society of Thoracic Surgeons Workforce on Evidence Based Surgery in 2024.
- A comprehensive literature search was performed using Medline for studies published in English over the past 15 years.
- A modified Delphi method was employed, with experts voting on statements using a 5-point Likert scale.
Main Results:
- Expert consensus statements were generated on critical management topics.
- Key areas addressed include vegetation size, pathogen impact, persistent bacteremia, prosthetic valve issues, surgical strategies, new technologies, and ethical concerns.
Conclusions:
- The consensus statements offer insights derived from literature and clinical experience.
- These statements aim to inform the management of tricuspid valve endocarditis in patients who inject drugs.
Background:
Tricuspid valve endocarditis in people who inject drugs represents a unique clinical and social challenge for cardiac surgeons. There is a relative paucity of research specific to this unique clinical scenario to guide evidence-based treatment.
Methods:
The Society of Thoracic Surgeons Workforce on Evidence Based Surgery assembled a writing group in 2024 to create an expert consensus document on the management of tricuspid endocarditis in people who inject drugs. A comprehensive literature search was conducted in Medline, focusing on studies published in English over the past 15 years. The consensus was reached using a modified Delphi method, with each member voting on statements via a 5-point Likert scale to assess wording and strength.
Results:
Expert consensus statements were generated addressing key topics including vegetation size, impact of infectious organism on surgical decision making, persistent bacteremia, prosthetic valve infections, surgical strategy, emerging technologies, and ethical considerations.
Conclusions:
Included expert consensus statements offers insight based on the literature a clinical experience about important topics when managing tricuspid valve endocarditis in patients who inject drugs.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Rheumatic Heart Disease III: Medical Management
Endocarditis IV: Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis